Lyell Immunopharma, Inc. (LYEL)
22.41
-1.19
(-5.04%)
USD |
NASDAQ |
Apr 24, 16:00
22.42
+0.01
(+0.04%)
After-Hours: 20:00
Lyell Immunopharma Total Assets (Quarterly) : 340.05M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Fortress Biotech, Inc. | 185.55M |
| Oramed Pharmaceuticals, Inc. | 230.86M |
| Climb Bio, Inc. | 167.74M |
| Moderna, Inc. | 12.34B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 91.85M |
| Shareholders Equity (Quarterly) | 248.20M |
| Debt to Equity Ratio | 0.2055 |
| Current Ratio | 5.281 |
| Net Debt Paydown Yield | 0.33% |